Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Any combination is set during the personalised peptide plan stage based on your clinical evaluation
Synopsis This study investigates the impact of excessive glutathione intake on breast cancer chemotherapy resistance, showing that higher intake is linked to increased recurrence rates and poor prognosis, emphasizing the need for standardized glutathione usage during treatment
Product Name: GHK-Cu Classification: Copper Peptide Complex Structural Description: Tripeptide-copper complex (Glycyl-L-histidyl-L-lysine:copper(II)) CAS Number: 89030-95-5 Molecular Weight: 402.92 g/mol (peptide + copper complex) Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
K., & Jawade, S
Some potential side effects include redness or pain at the injection site, nausea, headache, or diarrhea
For example, homologues with CxxS- and CxxC-motifs at the active site are classified as monothiol and dithiol glutaredoxins, respectively
